文献速递关节外科

盐水或血液稀释滑液会降低传统及新型滑液生物标志物的敏感性

Synovial Fluid Aspirates Diluted with Saline or Blood Reduce the Sensitivity of Traditional and Contemporary Synovial Fluid Biomarkers.
PubMed 文献 · Clin Orthop Relat Res · 2020-01-01

该研究分析了2016年至2019年间单实验室123,549份滑液样本,最终纳入71,116份,其中8%为盐水或血液严重稀释的低质量样本。低质量样本中,2018年ICM标准工具、滑液CRP、α-防御素、中性粒细胞弹性蛋白酶、白细胞计数和PMN百分比的敏感性均显著低于质量良好样本(所有p<0.001)。结论是严重稀释会人为降低检测敏感性,临床不应依赖阴性滑液结果排除PJI。

要点

  • 8%的滑液样本被盐水或血液严重稀释,定义为红细胞>1M cells/uL或OD280<0.324或>1.19。
  • 低质量样本中所有滑液标志物检测敏感性均显著降低,2018 ICM工具从97%降至83%。
  • 临床应避免依赖严重稀释的滑液阴性结果排除假体周围感染。

核心结论

  • 滑液被盐水或血液严重稀释时,所测生物标志物和细胞被稀释,降低实验室检测敏感性。
  • 建议未来诊断研究排除此类样本,以避免人为降低的检测敏感性。

研究设计与样本

  • 回顾性分析单实验室2016年1月至2019年7月提交的123,549份滑液样本,最终纳入71,116份(58%)。
  • 低质量样本定义为红细胞>1M cells/uL或OD280<0.324或>1.19,以滑液培养阳性作为参考诊断。

主要发现

  • 71,116份样本中8%(6025份)为低质量样本。
  • 低质量 vs 良好质量样本敏感性:2018 ICM工具83%(95%CI 80-86) vs 97%(95%CI 96-97)。
  • 滑液CRP 65%(95%CI 61-69) vs 88%(95%CI 87-89);α-防御素70%(95%CI 66-73) vs 93%(95%CI 93-94)。
  • 中性粒细胞弹性蛋白酶80%(95%CI 77-83) vs 96%(95%CI 96-97);白细胞计数69%(95%CI 65-73) vs 93%(95%CI 93-94)。
  • PMN百分比88%(95%CI 85-91) vs 95%(95%CI 94-95);所有比较p<0.001。

关键数值与推荐

  • 低质量滑液定义:红细胞>1M cells/uL或OD280<0.324或>1.19。
  • 以滑液培养阳性作为参考诊断定义PJI阳性样本。

临床怎么用

  • 临床医生应避免依赖严重稀释(盐水或血液为主)的滑液阴性检测结果排除PJI。
  • 未来诊断研究应排除严重稀释的滑液样本以准确评估检测性能。

局限性

  • 滑液培养假阴性率高,无法有效评估检测特异性,本研究未评估特异性。
  • 仅纳入髋、膝、肩关节置换样本,且部分样本因检测项目不足被排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent criteria-based diagnostic tools to diagnose periprosthetic infection (PJI), such as the International Consensus Meeting (ICM) definition of PJI, are heavily reliant on synovial fluid laboratory results. Despite the importance of synovial fluid in PJI diagnosis, the effect of the quality of synovial fluid aspirate on testing results has not been studied. Our laboratory has established quality control parameters to identify synovial fluid aspirates that are highly diluted by saline or blood, which appear to degrade the diagnostic performance of synovial fluid laboratory tests. QUESTIONS/PURPOSES: (1) What proportion of synovial fluid aspirates analyzed at one laboratory are of poor quality (defined as having a red blood count > 1M cells/uL or an optical density at 280 nm < 0.324 or > 1.19)? (2) Does a poor-quality aspirate decrease the sensitivities of International Consensus Meeting-based scores and other synovial fluid biomarker tests in terms of their ability to anticipate a positive culture? METHODS: From January 2016 to July 2019, a total of 123,549 synovial fluid samples were submitted to one laboratory for the purpose of diagnostic testing. Of these, 14% (16,773 of 123,549) samples were excluded because they were from a site other than a hip, knee, or shoulder arthroplasty, and an additional 33% (35,660 of 106,776) were excluded due to insufficient requested tests, resulting in 58% (71,116 of 123,549) samples included in this study. Specimens diluted with extreme levels of saline or blood were identified (defined as having a red blood count >1 M cells/uL or an optical density at 280 nm < 0.324 or > 1.19) as poor-quality aspirates. The sensitivities of synovial fluid C-reactive protein, alpha defensin, neutrophil elastase, white blood cell count, polymorphonuclear cell percentage, and the 2018 ICM-based tool were assessed in good-quality versus poor-quality synovial fluid samples. To avoid bias from using these evaluated tests within the reference definition of PJI in this study, a positive culture resulting from the synovial fluid served as the reference diagnosis defining a control cohort of PJI-positive samples. Although the low false-positive rate of synovial fluid culture allows for the valid estimation of synovial fluid test sensitivity, the high false-negative rate of synovial fluid culture prevents the valid estimation of test specificity, which was not evaluated in this study. RESULTS: Of the samples analyzed, 8% (6025 of 71,116) were found to have poor quality, in that they were substantially compromised by saline and/or blood. The sensitivity of all tests to detect culture-positive synovial fluid was lower in poor-quality than in good-quality samples: 2018 International Consensus Meeting-based tool (83% [95% CI 80 to 86] versus 97% [95% CI 96 to 97]), synovial fluid C-reactive protein (65% [95% CI 61 to 69] versus 88% [95% CI 87 to 89]), alpha defensin (70% [95% CI 66 to 73] versus 93% [95% CI 93 to 94]), neutrophil elastase (80% [95% CI 77 to 83] versus 96% [95% CI 96 to 97]), synovial fluid white blood cell count (69% [95% CI 65 to 73] versus 93% [95% CI 93 to 94]), and the polymorphonuclear cell percentage (88% [95% CI 85 to 91] versus 95% [95% CI 94 to 95]), with all p < 0.001. CONCLUSIONS: When synovial fluid is substantially diluted with saline or blood, the biomarkers and cells being measured are also diluted, decreasing the sensitivity of laboratory testing. We recommend that future diagnostic studies exclude these samples because an artificial reduction in test sensitivity will be observed. CLINICAL RELEVANCE: Clinicians should avoid relying on negative synovial fluid testing to rule out PJI when the fluid submitted is substantially constituted of saline or blood. Further studies are necessary to understand the diagnostic utility, if any, of these diluted aspirate samples.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Deirmengian C, Feeley S, Kazarian GS, et al. Synovial Fluid Aspirates Diluted with Saline or Blood Reduce the Sensitivity of Traditional and Contemporary Synovial Fluid Biomarkers. Clin Orthop Relat Res. 2020. PMID: 32191417. doi:10.1097/CORR.0000000000001188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。